AZS22-16 Antibody

What is the AZS22-16 Antibody and what are its primary applications?

AZS22-16 Antibody is a rabbit polyclonal antibody purified by Antigen Affinity that specifically targets the AZS22-16 protein in Zea mays. The antibody is unconjugated and primarily used for ELISA and Western Blot applications in plant-based research. It's particularly valuable for studying gene expression regulated by the Opaque2 (O2) transcription factor, which controls specific zein protein production in maize endosperm .

The antibody recognizes the protein product of the z1C2 gene (Entrez Gene ID: 541924, UniProt Number: P04700), which belongs to the α-zein 22-kD subfamily. This makes it an important tool for studying endosperm-specific gene expression and protein production in maize. When implementing the antibody in research protocols, it's essential to maintain storage at -20°C or -80°C to preserve its binding capacity and specificity.

How should AZS22-16 Antibody be stored and handled to maintain optimal activity?

For optimal maintenance of AZS22-16 Antibody reactivity, storage conditions are critical. The antibody should be stored at either -20°C or -80°C according to manufacturer specifications . When handling the antibody for experimental procedures, consider the following methodological approach:

• Aliquot the antibody upon receipt to minimize freeze-thaw cycles

• When thawing, keep the antibody on ice or at 4°C

• Avoid vortexing the antibody solution which can cause denaturation

• Centrifuge briefly before opening the tube to collect solution at the bottom

• Use sterile technique when handling to prevent contamination

Proper handling ensures experimental reproducibility and extends the usable life of the antibody preparation. For long-term storage beyond 6 months, -80°C is preferable to maintain epitope recognition capabilities.

What controls should be included when using AZS22-16 Antibody in experimental protocols?

When designing experiments with AZS22-16 Antibody, appropriate controls are essential for data validation. The antibody components include 200μg antigens (positive control) and 1ml pre-immune serum (negative control) alongside the purified rabbit polyclonal antibodies . A methodological approach to controls should include:

Including these controls ensures experimental rigor and helps distinguish genuine results from technical artifacts, particularly when studying gene expression patterns in different maize tissues or developmental stages.

What is the relationship between AZS22-16 and the Opaque2 regulatory pathway?

The AZS22-16 protein is encoded by one of the α-zein 22-kD subfamily genes, which are primary targets of the Opaque2 (O2) transcription factor in maize endosperm . O2 is an endosperm-specific bZIP-type transcription activator that regulates the expression of several genes involved in protein accumulation during kernel development.

The relationship functions through the following mechanism:

• Opaque2 binds to specific DNA sequences (O2-boxes) located approximately 300bp upstream of the ATG start codon in zein genes

• This binding initiates chromatin modifications, including cytosine demethylation at symmetric sites

• Transcriptionally silent chromatin (enriched with H3K9me2 and H3K27me2) is converted to active chromatin (enriched with H3K14ac and H3K4me2)

• The activated chromatin state allows RNA polymerase II binding and gene transcription

• AZS22-16, as part of the zein gene family, is specifically regulated through this pathway

Understanding this relationship is crucial for researchers using the AZS22-16 antibody to study endosperm development and protein accumulation patterns in wild-type versus O2 mutant maize lines.

How can AZS22-16 Antibody be used to investigate chromatin modifications in O2-regulated gene expression?

The AZS22-16 Antibody serves as a powerful tool for investigating the chromatin modification dynamics associated with O2-mediated gene regulation. Research has shown that O2 target genes undergo a two-step activation process involving specific chromatin states . To leverage this antibody for chromatin studies:

• Implement Chromatin Immunoprecipitation (ChIP) protocols using AZS22-16 Antibody in conjunction with antibodies against specific histone modifications:

  • H3K9me2 and H3K27me2 (repressive marks)

  • H3K14ac and H3K4me2/me3 (activating marks)

• Compare temporal patterns of AZS22-16 protein binding with chromatin state changes during endosperm development:

  • Early potentiated state: characterized by cytosine demethylation at symmetric sites

  • Later activated state: characterized by RNPII, O2, and Ada2/Gcn5 coactivator binding

• Perform sequential ChIP (re-ChIP) to determine co-occupancy of AZS22-16 with chromatin modifiers or O2 transcription factor

• Correlate ChIP findings with DNase I sensitivity assays to map changes in chromatin accessibility

This methodological approach allows researchers to determine how AZS22-16 protein interacts with the chromatin modification machinery and how its binding correlates with gene activation states in wild-type versus O2 mutant backgrounds.

What methodologies can resolve antibody cross-reactivity issues when studying closely related zein proteins?

When studying the α-zein 22-kD subfamily, which includes at least 15 clustered loci spanning a region of ~112kb on chromosome 4 in maize , cross-reactivity of the AZS22-16 Antibody with other closely related zein proteins presents a significant challenge. To address this:

• Implement epitope mapping to identify unique regions of AZS22-16:

  • Use peptide arrays containing overlapping sequences

  • Identify minimum epitope sequence for specific recognition

  • Design blocking peptides for validation experiments

• Employ differential extraction protocols based on physicochemical properties:

  • Sequential extraction with increasing concentrations of reducing agents

  • Size-exclusion chromatography prior to immunodetection

  • Isoelectric focusing followed by Western blotting

• Combine immunoprecipitation with mass spectrometry (IP-MS):

  • Pull down with AZS22-16 Antibody

  • Analyze peptide fragments using high-resolution MS

  • Compare peptide profiles to distinguish between related zeins

• Validate specificity using genetic resources:

  • Test antibody in null mutants for specific zein genes

  • Use RNAi lines with suppressed expression of individual zeins

  • Perform complementation tests with tagged zein variants

These advanced methodological approaches enable researchers to distinguish between closely related zein proteins, ensuring accurate interpretation of results when using the AZS22-16 Antibody in complex maize endosperm samples.

How can AZS22-16 Antibody be employed in studies of transgenic maize lines with modified O2 pathways?

The AZS22-16 Antibody provides a valuable tool for characterizing transgenic maize lines engineered to have modified O2 regulatory pathways. This application is particularly relevant for research into improved nutritional quality of maize. A methodological framework includes:

• Quantitative comparison of AZS22-16 protein levels across development:

  • Time-course sampling of developing endosperm (10-30 days post-pollination)

  • Comparative ELISA using AZS22-16 Antibody against wild-type and transgenic lines

  • Correlation of protein levels with transcript abundance via RT-qPCR

• Subcellular localization studies:

  • Immunohistochemistry with AZS22-16 Antibody on sectioned kernels

  • Co-localization with markers for protein bodies and other subcellular compartments

  • Analysis of trafficking changes in O2-modified lines

• Interaction proteomics:

  • Immunoprecipitation with AZS22-16 Antibody followed by mass spectrometry

  • Identification of differential protein interactions in transgenic versus wild-type lines

  • Validation of novel interactions through yeast-two-hybrid or BiFC assays

• Assessment of post-translational modifications:

  • 2D-gel electrophoresis followed by Western blotting with AZS22-16 Antibody

  • Phospho-specific detection methods to identify regulatory modifications

  • Correlation of modifications with protein functionality and accumulation patterns

This comprehensive approach enables researchers to fully characterize the impact of O2-pathway modifications on zein protein accumulation, providing insights for crop improvement strategies aimed at enhancing nutritional value.

What are the optimal conditions for using AZS22-16 Antibody in multiplexed immunoassays?

Multiplexed immunoassays allow simultaneous detection of multiple proteins, providing comprehensive insights into protein expression patterns and interactions. For optimal implementation of AZS22-16 Antibody in multiplexed formats:

• Antibody labeling considerations:

  • Select non-overlapping fluorophores when combining with other primary antibodies

  • Validate that conjugation doesn't affect epitope recognition

  • Determine optimal antibody concentration after labeling (typically 1-5 μg/ml)

• Sequential detection protocol for related proteins:

  • Begin with lowest abundance target using AZS22-16 Antibody

  • Strip and reprobe membranes using validated stripping buffers

  • Confirm complete stripping via negative control incubations

• Multiplex optimization matrix:

• Cross-reactivity control methodology:

  • Single-antibody controls for each target

  • Absorption controls with purified antigens

  • Computational subtraction of overlapping signals

Through systematic optimization, researchers can develop robust multiplexed assays incorporating AZS22-16 Antibody, enabling comprehensive analysis of zein protein family expression dynamics in diverse experimental contexts.

How can AZS22-16 Antibody be used to investigate epigenetic regulation during endosperm development?

The regulation of zein gene expression involves complex epigenetic mechanisms, including DNA methylation and histone modifications. AZS22-16 Antibody can be instrumental in dissecting these regulatory processes:

• Combined Bisulfite Restriction Analysis (COBRA) with immunodetection:

  • Analyze DNA methylation status at AZS22-16 promoter regions

  • Correlate methylation patterns with protein expression using the antibody

  • Compare wild-type and epigenetic modifier mutants (e.g., DNA methyltransferase mutants)

• Chromatin state analysis throughout development:

  • ChIP-seq for histone modifications at the AZS22-16 locus

  • Parallel protein quantification with AZS22-16 Antibody

  • Temporal mapping of chromatin changes with protein accumulation

Research has shown that O2-regulated genes exist in a transcriptionally silent chromatin state enriched with H3K9me2 and H3K27me2 in tissues where they are not expressed (e.g., leaves), while in endosperm, activation occurs through substitution with H3K14ac and H3K4me2 marks . AZS22-16 Antibody enables researchers to directly correlate these chromatin changes with protein accumulation patterns.

• Analysis of differently modified AZS22-16 protein isoforms:

  • 2D Western blot to separate protein variants

  • Mass spectrometry to identify post-translational modifications

  • Functional correlation of modifications with protein stability and accumulation

This methodological approach provides a comprehensive understanding of how epigenetic mechanisms influence AZS22-16 expression during endosperm development, contributing to broader knowledge of gene regulation in specialized plant tissues.